{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:32:13Z","timestamp":1790947933260,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029988"],"award-info":[{"award-number":["R01AA029988"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029988"],"award-info":[{"award-number":["R01AA029988"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029988"],"award-info":[{"award-number":["R01AA029988"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029988"],"award-info":[{"award-number":["R01AA029988"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029988"],"award-info":[{"award-number":["R01AA029988"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Disrupted lipogenic signaling and steatosis are key features of alcohol-associated liver disease (ALD). A-kinase anchoring protein 12 (AKAP12) is a scaffolding partner of the cAMP-dependent protein kinase, PKA that controls its spatiotemporal localization. Activation of PKA by cAMP inhibits lipogenesis and facilitates fatty acid oxidation (FAO). The goal of this work is to examine how AKAP12\u2019s PKA-anchoring ability regulates outcomes of alcohol-associated steatosis. Crosslinking proteomics identified PKA and its lipogenic substrates as interacting partners of AKAP12. Alcohol exposure diminished AKAP12\u2019s interaction with PKA regulatory subunits and PKA substrates, acetyl CoA carboxylase (ACC1), pyruvate dehydrogenase (PDHA) and adipose triglyceride lipase (ATGL). Alcohol inhibited PKA activity and increased triglyceride content in human hepatocytes. Forced expression of\n                    <jats:italic>AKAP12<\/jats:italic>\n                    restored alcohol suppressed PKA activation and inhibited lipid accumulation, whereas silencing had the reverse effect. Since\n                    <jats:italic>AKAP12<\/jats:italic>\n                    sustained PKA activity, we evaluated whether the AKAP12-PKA scaffold was important in lipid homeostasis. Inhibition of AKAP12-PKA interaction by CRISPR deletion of AKAP12\u2019s PKA binding domain in cultured hepatocytes or in mouse models of ALD dramatically suppressed PKA activity, enhanced ACC1 activity demonstrated by reduced inhibitory phosphorylation, increased lipid accumulation and reduced FAO in hepatocytes. Overexpression of\n                    <jats:italic>AKAP12<\/jats:italic>\n                    in mouse livers sustained PKA activation, diminished basal and alcohol potentiated triglyceride content, and regulated inflammatory signaling altered by alcohol. Mechanistically, we discovered that alcohol enhanced the inhibitory activity of a kinase, serine\/threonine-protein kinase 25 (STK25) on PKA that regulated its interaction with AKAP12. In conclusion, the AKAP12-PKA scaffold controls lipogenic signaling, disruption of which favors steatosis during ALD.\n                  <\/jats:p>","DOI":"10.1038\/s41392-025-02202-1","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:02:38Z","timestamp":1744138958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The AKAP12-PKA axis regulates lipid homeostasis during alcohol-associated liver disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Chandana","family":"Thimme Gowda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallikarjuna","family":"Siraganahalli Eshwaraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngyi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-9052","authenticated-orcid":false,"given":"Maria Lauda","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-3349","authenticated-orcid":false,"given":"Nirmala","family":"Mavila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-4603","authenticated-orcid":false,"given":"Komal","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"2202_CR1","first-page":"147","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna, N. A., Donohue, T. M. Jr & Kharbanda, K. K. Alcoholic liver disease: pathogenesis and current management. Alcohol Res. 38, 147\u2013161 (2017).","journal-title":"Alcohol Res."},{"key":"2202_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0140-6736(95)91685-7","volume":"346","author":"MR Teli","year":"1995","unstructured":"Teli, M. R., Day, C. P., Burt, A. D., Bennett, M. K. & James, O. F. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346, 987\u2013990 (1995).","journal-title":"Lancet"},{"key":"2202_CR3","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/biomedicines11082108","volume":"11","author":"K Staufer","year":"2023","unstructured":"Staufer, K. & Stauber, R. E. Steatotic liver disease: metabolic dysfunction, alcohol, or both? Biomedicines 11, 2108 (2023).","journal-title":"Biomedicines"},{"key":"2202_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-0030-1267538","volume":"30","author":"MS Sozio","year":"2010","unstructured":"Sozio, M. S., Liangpunsakul, S. & Crabb, D. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin Liver Dis. 30, 378\u2013390 (2010).","journal-title":"Semin Liver Dis."},{"key":"2202_CR5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1146\/annurev.bi.59.070190.004543","volume":"59","author":"SS Taylor","year":"1990","unstructured":"Taylor, S. S., Buechler, J. A. & Yonemoto, W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem. 59, 971\u20131005 (1990).","journal-title":"Annu. Rev. Biochem."},{"key":"2202_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cellsig.2018.06.005","volume":"49","author":"B Wahlang","year":"2018","unstructured":"Wahlang, B., McClain, C., Barve, S. & Gobejishvili, L. Role of cAMP and phosphodiesterase signaling in liver health and disease. Cell Signal 49, 105\u2013115 (2018).","journal-title":"Cell Signal"},{"key":"2202_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1432-1033.1984.tb08105.x","volume":"140","author":"R Holland","year":"1984","unstructured":"Holland, R., Witters, L. A. & Hardie, D. G. Glucagon inhibits fatty acid synthesis in isolated hepatocytes via phosphorylation of acetyl-CoA carboxylase by cyclic-AMP-dependent protein kinase. Eur. J. Biochem. 140, 325\u2013333 (1984).","journal-title":"Eur. J. Biochem."},{"key":"2202_CR8","doi-asserted-by":"publisher","first-page":"836058","DOI":"10.3389\/fonc.2022.836058","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Acetyl-CoA carboxylases and diseases. Front. Oncol. 12, 836058 (2022).","journal-title":"Front. Oncol."},{"key":"2202_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","volume":"29","author":"JSV Lally","year":"2019","unstructured":"Lally, J. S. V. et al. Inhibition of Acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma. Cell Metab. 29, 174\u2013182 (2019).","journal-title":"Cell Metab."},{"key":"2202_CR10","doi-asserted-by":"publisher","first-page":"1129010","DOI":"10.3389\/fphar.2023.1129010","volume":"14","author":"Y Yu","year":"2023","unstructured":"Yu, Y. et al. Targeting acetyl-CoA carboxylase 1 for cancer therapy. Front. Pharmacol. 14, 1129010 (2023).","journal-title":"Front. Pharmacol."},{"key":"2202_CR11","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/0003-9861(83)90113-3","volume":"225","author":"BA Lent","year":"1983","unstructured":"Lent, B. A. & Kim, K. H. Phosphorylation and activation of acetyl-coenzyme A Carboxylase kinase by the catalytic subunit of cyclic AMP-dependent protein kinase. Arch. Biochem. Biophys. 225, 972\u2013978 (1983).","journal-title":"Arch. Biochem. Biophys."},{"key":"2202_CR12","doi-asserted-by":"publisher","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","volume":"113","author":"G Harriman","year":"2016","unstructured":"Harriman, G. et al. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. Proc. Natl. Acad. Sci. USA 113, E1796\u2013E1805 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2202_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35085068","volume":"2","author":"B Mayr","year":"2001","unstructured":"Mayr, B. & Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599\u2013609 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2202_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature02110","volume":"426","author":"S Herzig","year":"2003","unstructured":"Herzig, S. et al. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature 426, 190\u2013193 (2003).","journal-title":"Nature"},{"key":"2202_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep32246","volume":"6","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis. Sci. Rep. 6, 32246 (2016).","journal-title":"Sci. Rep."},{"key":"2202_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver, P. & Spiegelman, B. M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24, 78\u201390 (2003).","journal-title":"Endocr. Rev."},{"key":"2202_CR17","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/JOE-20-0035","volume":"246","author":"E London","year":"2020","unstructured":"London, E., Bloyd, M. & Stratakis, C. A. PKA functions in metabolism and resistance to obesity: lessons from mouse and human studies. J. Endocrinol. 246, R51\u2013R64 (2020).","journal-title":"J. Endocrinol."},{"key":"2202_CR18","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","volume":"185","author":"AY Wen","year":"2010","unstructured":"Wen, A. Y., Sakamoto, K. M. & Miller, L. S. The role of the transcription factor CREB in immune function. J. Immunol. 185, 6413\u20136419 (2010).","journal-title":"J. Immunol."},{"key":"2202_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12986-019-0400-5","volume":"16","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. Hepatic PKA inhibition accelerates the lipid accumulation in liver. Nutr. Metab. 16, 69 (2019).","journal-title":"Nutr. Metab."},{"key":"2202_CR20","doi-asserted-by":"publisher","first-page":"A16","DOI":"10.2741\/gouillon","volume":"4","author":"ZQ Gouillon","year":"1999","unstructured":"Gouillon, Z. Q. et al. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway. Front. Biosci. 4, A16\u2013A25 (1999).","journal-title":"Front. Biosci."},{"key":"2202_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/path.4760","volume":"240","author":"DV Avila","year":"2016","unstructured":"Avila, D. V. et al. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis. J. Pathol. 240, 96\u2013107 (2016).","journal-title":"J. Pathol."},{"key":"2202_CR22","doi-asserted-by":"publisher","first-page":"9079","DOI":"10.1074\/jbc.M110.160614","volume":"286","author":"F Christian","year":"2011","unstructured":"Christian, F. et al. Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J. Biol. Chem. 286, 9079\u20139096 (2011).","journal-title":"J. Biol. Chem."},{"key":"2202_CR23","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1093\/emboj\/cdg628","volume":"22","author":"J Tao","year":"2003","unstructured":"Tao, J., Wang, H. Y. & Malbon, C. C. Protein kinase A regulates AKAP250 scaffold binding to the beta2-adrenergic receptor. EMBO J. 22, 6419\u20136429 (2003).","journal-title":"EMBO J."},{"key":"2202_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-3-19","volume":"3","author":"J Tao","year":"2008","unstructured":"Tao, J. & Malbon, C. C. G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. J. Mol. Signal 3, 19 (2008).","journal-title":"J. Mol. Signal"},{"key":"2202_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/cells12030436","volume":"12","author":"H Subramanian","year":"2023","unstructured":"Subramanian, H. & Nikolaev, V. O. A-kinase anchoring proteins in cardiac myocytes and their roles in regulating calcium cycling. Cells 12, 436 (2023).","journal-title":"Cells"},{"key":"2202_CR26","doi-asserted-by":"publisher","first-page":"529179","DOI":"10.1155\/2012\/529179","volume":"2012","author":"S Akakura","year":"2012","unstructured":"Akakura, S. & Gelman, I. H. Pivotal role of AKAP12 in the regulation of cellular adhesion dynamics: control of cytoskeletal architecture, cell migration, and mitogenic signaling. J. Signal Transduct. 2012, 529179 (2012).","journal-title":"J. Signal Transduct."},{"key":"2202_CR27","first-page":"2304","volume":"57","author":"X Lin","year":"1997","unstructured":"Lin, X. & Gelman, I. H. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Cancer Res. 57, 2304\u20132312 (1997).","journal-title":"Cancer Res."},{"key":"2202_CR28","doi-asserted-by":"publisher","first-page":"e78430","DOI":"10.7554\/eLife.78430","volume":"11","author":"K Ramani","year":"2022","unstructured":"Ramani, K. et al. Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models. Elife 11, e78430 (2022).","journal-title":"Elife"},{"key":"2202_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0187-x","volume":"50","author":"HS Lee","year":"2018","unstructured":"Lee, H. S. et al. Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution. Exp. Mol. Med. 50, 1\u201313 (2018).","journal-title":"Exp. Mol. Med."},{"key":"2202_CR30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ajpath.2017.11.017","volume":"188","author":"K Ramani","year":"2018","unstructured":"Ramani, K., Tomasi, M. L., Berlind, J., Mavila, N. & Sun, Z. Role of A-kinase anchoring protein phosphorylation in alcohol-induced liver injury and hepatic stellate cell activation. Am. J. Pathol. 188, 640\u2013655 (2018).","journal-title":"Am. J. Pathol."},{"key":"2202_CR31","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/hep.23939","volume":"52","author":"B Goeppert","year":"2010","unstructured":"Goeppert, B. et al. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 52, 2023\u20132033 (2010).","journal-title":"Hepatology"},{"key":"2202_CR32","doi-asserted-by":"publisher","first-page":"102328","DOI":"10.1016\/j.redox.2022.102328","volume":"53","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. AKAP12 ameliorates liver injury via targeting PI3K\/AKT\/PCSK6 pathway. Redox Biol. 53, 102328 (2022).","journal-title":"Redox Biol."},{"key":"2202_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-023-02257-1","volume":"10","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases. Sci. Data 10, 376 (2023).","journal-title":"Sci. Data"},{"key":"2202_CR34","doi-asserted-by":"publisher","first-page":"109754","DOI":"10.1016\/j.biopha.2019.109754","volume":"122","author":"S Han","year":"2020","unstructured":"Han, S. et al. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12. Biomed. Pharmacother. 122, 109754 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"2202_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2015.11.017","volume":"71","author":"W Xia","year":"2016","unstructured":"Xia, W. et al. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12. Int. J. Biochem. Cell Biol. 71, 1\u201311 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2202_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0960-9822(06)00027-3","volume":"7","author":"JB Nauert","year":"1997","unstructured":"Nauert, J. B., Klauck, T. M., Langeberg, L. K. & Scott, J. D. Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr. Biol. 7, 52\u201362 (1997).","journal-title":"Curr. Biol."},{"key":"2202_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1937-6448(10)83005-9","volume":"283","author":"P Skroblin","year":"2010","unstructured":"Skroblin, P., Grossmann, S., Sch\u00e4fer, G., Rosenthal, W. & Klussmann, E. Mechanisms of protein kinase A anchoring. Int. Rev. Cell Mol. Biol. 283, 235\u2013330 (2010).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"2202_CR38","doi-asserted-by":"publisher","first-page":"111203","DOI":"10.1016\/j.celrep.2022.111203","volume":"40","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. STK25 inhibits PKA signaling by phosphorylating PRKAR1A. Cell Rep. 40, 111203 (2022).","journal-title":"Cell Rep."},{"key":"2202_CR39","doi-asserted-by":"publisher","first-page":"11815","DOI":"10.1074\/jbc.M117.777748","volume":"292","author":"MB Schott","year":"2017","unstructured":"Schott, M. B. et al. \u03b2-Adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure. J. Biol. Chem. 292, 11815\u201311828 (2017).","journal-title":"J. Biol. Chem."},{"key":"2202_CR40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1074\/mcp.M800226-MCP200","volume":"8","author":"TT Aye","year":"2009","unstructured":"Aye, T. T. et al. Selectivity in enrichment of cAMP-dependent protein kinase regulatory subunits type I and type II and their interactors using modified cAMP affinity resins. Mol. Cell Proteomic. 8, 1016\u20131028 (2009).","journal-title":"Mol. Cell Proteomic."},{"key":"2202_CR41","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","volume":"24","author":"JL Torres","year":"2018","unstructured":"Torres, J. L. et al. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J. Gastroenterol. 24, 4104\u20134118 (2018).","journal-title":"World J. Gastroenterol."},{"key":"2202_CR42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3892\/mmr.2014.2368","volume":"10","author":"YP Chen","year":"2014","unstructured":"Chen, Y. P., Jin, X., Kong, M. & Li, Y. M. Pattern of microRNA expression associated with different stages of alcoholic liver disease in rat models. Mol. Med. Rep. 10, 1195\u20131204 (2014).","journal-title":"Mol. Med. Rep."},{"key":"2202_CR43","doi-asserted-by":"publisher","first-page":"e97118","DOI":"10.1371\/journal.pone.0097118","volume":"9","author":"RM Carr","year":"2014","unstructured":"Carr, R. M., Peralta, G., Yin, X. & Ahima, R. S. Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice. PLoS One 9, e97118 (2014).","journal-title":"PLoS One"},{"key":"2202_CR44","doi-asserted-by":"publisher","first-page":"G726","DOI":"10.1152\/ajpgi.00436.2015","volume":"310","author":"CP Najt","year":"2016","unstructured":"Najt, C. P. et al. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G726\u2013G738 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2202_CR45","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1530-0277.2011.01434.x","volume":"35","author":"DJ Orlicky","year":"2011","unstructured":"Orlicky, D. J. et al. Chronic ethanol consumption in mice alters hepatocyte lipid droplet properties. Alcohol Clin. Exp. Res. 35, 1020\u20131033 (2011).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"2202_CR46","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.2174\/1381612824666180410091511","volume":"24","author":"Y Lu","year":"2019","unstructured":"Lu, Y. & Cederbaum, A. I. Cytochrome P450s and alcoholic liver disease. Curr. Pharm. Des. 24, 1502\u20131517 (2019).","journal-title":"Curr. Pharm. Des."},{"key":"2202_CR47","doi-asserted-by":"publisher","first-page":"e68845","DOI":"10.1371\/journal.pone.0068845","volume":"8","author":"D Chanda","year":"2013","unstructured":"Chanda, D. et al. Hepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH. PLoS One 8, e68845 (2013).","journal-title":"PLoS One"},{"key":"2202_CR48","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/biomedicines12071505","volume":"12","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Reducing oxidative stress-mediated alcoholic liver injury by multiplexed RNAi of Cyp2e1, Cyp4a10, and Cyp4a14. Biomedicines 12, 1505 (2024).","journal-title":"Biomedicines"},{"key":"2202_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jcmgh.2018.12.004","volume":"7","author":"E Cansby","year":"2019","unstructured":"Cansby, E. et al. Targeted delivery of Stk25 antisense oligonucleotides to hepatocytes protects mice against nonalcoholic fatty liver disease. Cell Mol. Gastroenterol. Hepatol. 7, 597\u2013618 (2019).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2202_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola, A., Mathews, S., Ki, S. H., Wang, H. & Gao, B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat. Protoc. 8, 627\u2013637 (2013).","journal-title":"Nat. Protoc."},{"key":"2202_CR51","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.redox.2014.09.007","volume":"2","author":"AI Cederbaum","year":"2014","unstructured":"Cederbaum, A. I. Methodology to assay CYP2E1 mixed function oxidase catalytic activity and its induction. Redox Biol. 2, 1048\u20131054 (2014).","journal-title":"Redox Biol."},{"key":"2202_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02202-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:02:38Z","timestamp":1744138958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02202-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2202"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02202-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}